Gliead is rapidly working to
fight with this outbreak of novel COVID-19. Remdesivir is a
potential drug for the treatment for COVID-19. Remdesivir has
formally not been approved as treatment of COVID-19. USA is using
appropriate authorities for the investigation of the drug. That
there are multiple clinical trials going on check safety and
efficiency of the drug Remdesivir Covid-19 treatment.
Gilead is working with regulatory
agencies to provide remdesivir to the patients. Till date Gliead is
providing the emergency access to remdesivir for several hundred
patients in the United States, Europe and Japan
According to the report of
medical news website STAT the drug Remdesivir is showing positive
response to the patients of COVID-19. The University of Chicago
Medical centre has also participating in the study of the antiviral
medication and said that there are rapid recoveries of the symptoms
of Covid-19 because of this drug. The drug Remdesivir has earlier
tested
